A New Era in Oncology: Tennessee's $20 Million Leap into Radiopharmaceutical Research
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Stage IV Bladder Cancer AJCC v8
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB02379
Beta-D-Glucose
1
Completed
1
DB08875
Cabozantinib
1
Active Not Recruiting
1
DB00958
Carboplatin
1
Completed
1
DB14547
Chloride ion
1
Completed
1
DB00515
Cisplatin
1
Completed
1
DB01248
Docetaxel
1
Completed
1
DB13007
Enfortumab vedotin
1
Recruiting
1
DB12147
Erdafitinib
1
Recruiting
1
DB00773
Etoposide
1
Completed
1
DB06186
Ipilimumab
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Completed
1
DB12257
Platinum
1
Completed
1
DB11595
Atezolizumab
1 / 2
Recruiting
1
DB11945
Avelumab
1 / 2
Recruiting
1
DB11714
Durvalumab
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Recruiting
1
DB09037
Pembrolizumab
1 / 2
Active Not Recruiting
1
DB09037
Pembrolizumab
1 / 2
Recruiting
1
DB05992
Plinabulin
1 / 2
Recruiting
1
DB12887
Tazemetostat
1 / 2
Active Not Recruiting
1
DB11595
Atezolizumab
2
Active Not Recruiting
2
DB11945
Avelumab
2
Recruiting
1
DB08875
Cabozantinib
2
Recruiting
1
DB11714
Durvalumab
2
Active Not Recruiting
1
DB13007
Enfortumab vedotin
2
Recruiting
1
DB08871
Eribulin
2
Active Not Recruiting
1
DB11997
Interleukin-7
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Recruiting
3
DB09074
Olaparib
2
Recruiting
1
DB09037
Pembrolizumab
2
Recruiting
3
DB00571
Propranolol
2
Recruiting
1
DB14851
Relatlimab
2
Recruiting
1
DB06273
Tocilizumab
2
Active Not Recruiting
1
DB11771
Tremelimumab
2
Active Not Recruiting
1
DB11945
Avelumab
3
Active Not Recruiting
1
DB08875
Cabozantinib
3
Active Not Recruiting
1
DB01248
Docetaxel
3
Recruiting
1
DB08871
Eribulin
3
Recruiting
1
DB00441
Gemcitabine
3
Recruiting
1
DB01229
Paclitaxel
3
Recruiting
1
DB12893
Sacituzumab govitecan
3
Recruiting
1